FDA approves evolocumab for strokes, heart attacks

On Dec. 1, the U.S. Food and Drug Administration approved the PCSK9 inhibitor evolocumab (Repatha) to prevent heart attacks and strokes. It is the first PCSK9 approved for these conditions in adults with cardiovascular disease, notes Amgen in a release. Many patients, who had already been receiving the best therapies available, remained at high risk […]

Adults with hypertension can lower their blood pressure by consuming less sodium and sticking to the Dietary Approaches to Stop Hypertension (DASH) diet. That’s according to preliminary data presented at the American Heart Association’s Scientific Sessions 2017 in Anaheim. Researchers, led by Stephen Juraschek, of Beth Israel Deaconess Medical Center, studied 412 adults of varying […]